Original Research

Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents

Ayoub NM, Al-Shami KM, Alqudah MA, Mhaidat NM

OncoTargets and Therapy 2017, 10:4869-4883

Published Date: 5 October 2017